Agenda - New York

6:30 – 7:30 AM 

 

Registration and Networking Breakfast

     

7:30 – 7:40 AM

 

Introduction and Pre-Activity Assessment

     
7:40 – 8:10 AM  

Leukemia/Lymphoma
Richard R. Furman, MD
Weill Cornell Medicine/New York Presbyterian Hospital

     

8:10 – 8:40 AM

 

Healthcare Delivery and Survivorship
Carrie Tompkins Stricker, PhD, RN, AOCN®
Carevive Systems, Inc.

     

8:40 – 9:40 AM

 

Hepatobiliary/Pancreatic/Gastrointestinal Cancers
Rachna Shroff, MD, MS
University of Arizona Cancer Center

     

9:40 – 10:05 AM

 

Networking Break

     
10:05 – 10:35 AM  

Melanoma and Skin Cancers
Michael Postow, MD
Memorial Sloan Kettering Cancer Center

     
10:35 – 11:05 AM  

Gynecologic Cancers
Premal Thaker, MD, MS
Washington University School of Medicine

     
11:05 – 11:40 AM  

Genitourinary Cancers
Evan Y. Yu, MD
University of Washington; Fred Hutchinson Cancer Research Center


 

 

11:40 AM – 12:25 PM    Networking Lunch 
     
12:25 – 12:55 PM  

Breast Cancer
Joseph A. Sparano, MD
Montefiore Medical Center; Albert Einstein Cancer Center, Albert Einstein College of Medicine

     
12:55 – 1:25 PM  

Multiple Myeloma
Sundar Jagannath, MD, FACP
Icahn School of Medicine at Mount Sinai; Tisch Cancer Institute

     
1:25 – 1:55 PM  

CAR T-cell Therapies
Krishna Komanduri, MD
Sylvester Comprehensive Cancer Center, University of Miami

     
1:55 – 2:25 PM  

Quality Management and Care Improvement
Keith D. Eaton, MD, PhD
University of Washington; Seattle Cancer Care Alliance

     
2:25 – 2:45 PM   

Networking Break


 

 

2:45 – 3:15 PM     Cancer Genomics and Molecular Diagnostics
Jeffrey Gregg, MD
University of California, Davis Medical Center; Foundation Medicine, Inc. 

 

 

3:15 – 3:45 PM    Lung Cancer
Jamie Chaft, MD
Memorial Sloan Kettering Cancer Center

 

 

3:45 – 4:00 PM    Program Evaluation/Q&A 

Agenda subject to change.

Co-Hosts

ESHOS-logo-200x90    logo-ACCC-200x80

Supporters

This activity is supported in part by educational grants from Astellas and Seattle Genetics, Celgene Corporation, Daiichi Sankyo, Inc., Exelixis, Inc., Pfizer, Inc., TESARO, Inc. and educational funding by Amgen.